Midway Specialty Care Center · Miami Beach, FL
Board-certified infectious disease specialists providing expert hepatitis B and C diagnosis, treatment, and long-term liver health monitoring.
Hepatitis Care in Miami Beach
Hepatitis B and C are serious liver infections caused by viruses that can be transmitted through blood, sexual contact, or from mother to child. Left untreated, both can lead to chronic liver disease, cirrhosis, or liver cancer — but with the right care, outcomes have dramatically improved. Hepatitis C is now curable in the vast majority of patients, and hepatitis B can be effectively managed long-term.
At Midway Specialty Care Center in Miami Beach, our infectious disease physicians specialize in the diagnosis and treatment of viral hepatitis. We provide individualized care plans, access to the latest FDA-approved therapies, and the ongoing liver monitoring needed to protect your health over the long term.
Whether you were recently diagnosed, referred by another physician, or have been living with hepatitis for years without treatment, we're ready to help.
Comprehensive evaluation, treatment, and monitoring.
Modern direct-acting antiviral (DAA) therapy can cure hepatitis C in more than 95% of patients — often with just 8–12 weeks of once-daily oral medication. We determine the best DAA regimen based on your viral genotype, liver fibrosis stage, and prior treatment history, and provide close monitoring throughout to confirm cure.
Unlike hepatitis C, chronic hepatitis B currently has no cure, but it can be effectively managed with antiviral therapy to suppress viral replication, protect liver function, and reduce the risk of cirrhosis and liver cancer. We evaluate whether treatment is indicated based on viral load, liver enzymes, and fibrosis stage, and provide long-term follow-up care.
Regular laboratory testing is central to hepatitis management. We monitor liver enzyme levels (ALT/AST), viral load, hepatitis antigen and antibody markers, and bilirubin — tracking how your liver is responding to treatment and whether the virus is being suppressed or eliminated. Monitoring frequency is tailored to your specific situation.
Direct-acting antiviral medications for hepatitis C can cost tens of thousands of dollars without assistance. As a federally qualified 340B nonprofit clinic, we can provide these medications at dramatically reduced costs for eligible patients. Our team also assists with insurance prior authorizations and pharmaceutical patient assistance programs.
HIV and hepatitis C frequently occur together, and HIV infection can accelerate liver disease progression in patients with hepatitis. Our infectious disease physicians are experienced in managing co-infected patients — coordinating HIV antiretroviral therapy alongside hepatitis treatment for optimal outcomes in both conditions.
Board-certified specialists with expertise in hepatitis B and C treatment.
MD, FACP
Cynthia I Rivera, M.D., F.A.C. P. is an Infectious Diseases specialist and the Associate Program Director for the Internal Medicine Residency at Mount Sinai Medical Center in Miami Beach, Florida. Dr. Rivera is a graduate of University of Nebraska Medical Center. Dr. Rivera then moved to Miami to complete an Internship and Residency in Internal Medicine at University of Miami/Jackson Memorial Hospital. After a year as Chief Medical Resident and another year specializing in medical education, she started her Infectious Diseases fellowship, also at University of Miami/Jackson Memorial Hospital. Upon completion of her Infectious Diseases Fellowship, she joined a private practice. Her interests include: medical education, treatment and prevention of HIV, maintenance of overall sexual health, wellness initiatives and treatment of patients with hepatitis C, both mono-infected and co-infected with HIV. In addition, she serves on the board of directors of Mindo Futures, a 501c3 organization dedicated to health and educational initiatives in rural Ecuador and elsewhere.
MD, FACP
Cynthia I Rivera, M.D., F.A.C. P. is an Infectious Diseases specialist and the Associate Program Director for the Internal Medicine Residency at Mount Sinai Medical Center in Miami Beach, Florida. Dr. Rivera is a graduate of University of Nebraska Medical Center. Dr. Rivera then moved to Miami to complete an Internship and Residency in Internal Medicine at University of Miami/Jackson Memorial Hospital. After a year as Chief Medical Resident and another year specializing in medical education, she started her Infectious Diseases fellowship, also at University of Miami/Jackson Memorial Hospital. Upon completion of her Infectious Diseases Fellowship, she joined a private practice. Her interests include: medical education, treatment and prevention of HIV, maintenance of overall sexual health, wellness initiatives and treatment of patients with hepatitis C, both mono-infected and co-infected with HIV. In addition, she serves on the board of directors of Mindo Futures, a 501c3 organization dedicated to health and educational initiatives in rural Ecuador and elsewhere.
View Full Profile →
MD, FACP
MD, FACP
View Full Profile →
DO
DO
View Full Profile →
MD
MD
View Full Profile →
Our clinic treats patients at every stage of disease.
If you've recently tested positive for hepatitis B or C, we'll walk you through what your diagnosis means, what testing is needed to understand your liver health, and what treatment options are available — clearly and without alarm.
Many people live with hepatitis B or C for years without treatment — either because they weren't aware of treatment options or faced barriers to access. It's not too late to start. Modern therapies are far more effective and tolerable than older regimens.
Patients living with HIV who also have hepatitis B or C require specialized care that addresses both infections simultaneously. Our infectious disease team manages co-infected patients with the depth of expertise both conditions demand.
Moving your hepatitis care to a new provider is straightforward. We'll review your prior records, continue or adjust your current management plan, and provide coordinated follow-up — including any needed imaging or referrals.
Getting the right evaluation is the first step toward effective treatment.
Call our Miami Beach office at (305) 674-2766 or submit the request form. If you have prior lab results or records from another provider, bring them along — they help us understand where you are in your diagnosis and avoid duplicating tests already completed.
Your provider will review your health history and order any needed lab work — including viral load, genotype testing for hepatitis C, liver enzyme panels, and hepatitis antigen/antibody markers. For patients with known disease, we assess the degree of liver fibrosis to guide treatment decisions.
Once results are reviewed, your provider will discuss your treatment options in plain language. For hepatitis C, we'll select the right DAA regimen and handle any insurance prior authorization. For hepatitis B, we'll determine whether antiviral therapy is indicated now or whether monitoring is the appropriate first step.
For hepatitis C patients on DAA therapy, follow-up labs are scheduled during and after treatment to confirm the virus is clearing. Cure is confirmed with a sustained virologic response (SVR) 12 weeks after completing treatment. Hepatitis B patients receive regular liver function monitoring on a schedule based on viral activity and treatment status.
Miami Beach · Hepatitis B & C
4308 Alton Rd, Suite 860
Miami Beach, FL 33140
Clinic Fax
(305) 674-2765
After your appointment is confirmed, you'll receive a link to complete your intake forms online before your visit — from any device, no printing required.
Prefer Paper?
Download and print the forms below if you'd like to complete them by hand before your visit.
“Thank you Midway and staff for providing healing hands. It is rare that you find such kind and dedicated people. I'm forever grateful.”
— Steven C.